Mankind Pharma

The Exchange has sought clarification from Mankind Pharma Ltd on February 27, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

27 Feb, 2026 | 11:58am • Source: BSE

Please find attached intimation under Regulation 30 of SEBI LODR Regulations, 2015

26 Feb, 2026 | 06:24pm • Source: BSE

Intimation regarding reaffirmaiton of Credit Ratings

24 Feb, 2026 | 06:20pm • Source: BSE

Please find attached intimation of participation in Investor Conference

18 Feb, 2026 | 03:03pm • Source: BSE

Please find attached disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

16 Feb, 2026 | 06:49pm • Source: BSE

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09 Feb, 2026 | 03:01pm • Source: BSE

Please find enclosed herewith the transcript of the investor conference call for Q3 & 9M FY26 held on February 3, 2026.

09 Feb, 2026 | 01:37pm • Source: BSE

Please find attached intimation regarding newspaper advertisement - Unaudited Financial Results of the Company for Q3 FY26

04 Feb, 2026 | 02:09pm • Source: BSE

Please find attached intimation of participation in Investor Conference

04 Feb, 2026 | 01:45pm • Source: BSE

Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q3 & 9M FY26

03 Feb, 2026 | 09:53pm • Source: BSE

Compliance Certificate under Regulation 54 of SEBI LODR for Q3 FY26

03 Feb, 2026 | 04:25pm • Source: BSE

Investor Presentation of Q3 FY26 for financial results

03 Feb, 2026 | 04:21pm • Source: BSE

Press Release for Q3 FY26

03 Feb, 2026 | 04:20pm • Source: BSE

Outcome of Board Meeting

03 Feb, 2026 | 04:18pm • Source: BSE

Please find attached the Unaudited Financial Results for the quarter and nine months ended December 31, 2025

03 Feb, 2026 | 04:14pm • Source: BSE

Please find attached Intimation regarding withdrawal and outstanding Credit Ratings granted by ICRA Limited

16 Jan, 2026 | 06:27pm • Source: BSE

Please find attached intimation regarding Investor Conference Call for Q3 & 9M FY26 with Senior Management

16 Jan, 2026 | 03:22pm • Source: BSE

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and...

09 Jan, 2026 | 11:53am • Source: BSE

Please find attached Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025.

05 Jan, 2026 | 04:06pm • Source: BSE

Please find attached, intimation regarding Closure of the Trading Window

24 Dec, 2025 | 01:34pm • Source: BSE